Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alcidion GroupASX:ALC +1.03% EV-to-EBITDA is 13.83 as of Jul. 19, 2026. The stock has 4 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Alcidion Group ranks worse than 59.88% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alcidion Group's enterprise value is A$118.47 Mil.
Alcidion Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$8.57 Mil. Therefore, Alcidion Group's EV-to-EBITDA for today is 13.83.
The historical rank and industry rank for Alcidion Group's EV-to-EBITDA or its related term are showing as below:
ASX:ALC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2592.71 Med: -26.33 Max: 30.35
Current: 13.83
During the past 13 years, the highest EV-to-EBITDA of Alcidion Group was 30.35. The lowest was -2592.71. And the median was -26.33.
ASX:ALC's EV-to-EBITDA is ranked worse than 59.88% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs ASX:ALC: 13.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Alcidion Group (ASX:ALC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alcidion Group's PE Ratio (TTM) for today is calculated as:
Alcidion Group's share price for today is A$0.098.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Alcidion Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Alcidion Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alcidion Group's EV-to-EBITDA falls into.
Alcidion Group's current Enterprise Value is A$118.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alcidion Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$8.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a EV-to-EBITDA of 13.83 as of Jul. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alcidion Group. According to the industry distribution chart, Alcidion Group ranks #303 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 59.9%.
Is Alcidion Group's EV-to-EBITDA too high?
Alcidion Group's current EV-to-EBITDA is 13.83. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.10. Alcidion Group's value of 13.83 is 24.6% above this industry median. Based on the distribution chart, Alcidion Group ranks #303 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Alcidion Group's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #303 out of 506 companies for EV-to-EBITDA. This places Alcidion Group in the lower half of its industry. The industry median EV-to-EBITDA is 11.10. Alcidion Group's value of 13.83 is 24.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.10, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current EV-to-EBITDA of 13.83 is 24.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alcidion Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current EV-to-EBITDA is 13.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 18.3% below its estimated fair value. The current EV-to-EBITDA is 13.83 and 24.6% above the Healthcare Providers & Services industry median of 11.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current EV-to-EBITDA is 13.83 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
